Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,213 | -12,698 | -9,785 | -6,470 | -3,290 |
| Depreciation Amortization | -243 | 37 | 28 | 25 | 13 |
| Accounts receivable | N/A | 97 | -140 | 52 | -121 |
| Other Working Capital | -503 | 526 | -447 | 160 | -292 |
| Other Operating Activity | 1,055 | 4,703 | 3,936 | 2,468 | 1,381 |
| Operating Cash Flow | $-2,904 | $-7,335 | $-6,408 | $-3,765 | $-2,309 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,703 | 4,276 | 3,409 | 685 | 129 |
| Investing Cash Flow | $2,703 | $4,276 | $3,409 | $685 | $129 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 3,421 | 3,309 | 131 | 67 |
| Common Stock Repurchased | N/A | -6 | N/A | N/A | N/A |
| Other Financing Activity | -17 | 0 | 0 | 3,029 | 2,196 |
| Financing Cash Flow | $-17 | $3,415 | $3,309 | $3,160 | $2,263 |
| Beginning Cash Position | 1,271 | 915 | 915 | 915 | 915 |
| End Cash Position | 1,053 | 1,271 | 1,225 | 995 | 998 |
| Net Cash Flow | $-218 | $356 | $310 | $80 | $83 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,904 | -7,335 | -6,408 | -3,765 | -2,309 |
| Free Cash Flow | -2,904 | -7,335 | -6,408 | -3,765 | -2,309 |